Table 2.
Transplant Characteristics
| UD (%) | RD (%) | Haplo (%) | p value | |
|---|---|---|---|---|
| Donor-recipient Sex | 0.26 | |||
| MM | 19 (44) | 7 (22) | 9 (37) | |
| MF | 5 (11) | 11 (34) | 6 (25) | |
| FM | 13 (30) | 8 (25) | 6 (25) | |
| FF | 6 (14) | 6 (19) | 3 (13) | |
| Donor-recipient CMV status (%) | 0.47 | |||
| +/+ | 9 (21) | 11 (34) | 7 (29) | |
| +/− | 8 (19) | 2 (6) | 7 (29) | |
| −/+ | 13 (30) | 8 (25) | 5 (21) | |
| −/− | 13 (30) | 11 (34) | 5 (21) | |
| Degree of HLA Match* (%) | <0.001 | |||
| Well-Matched | 35 (81) | 32 (100) | N/A | |
| Partially-Matched | 6 (14) | 0 (0) | 24 (100) | |
| Mismatched | 2 (5) | 0 (0) | N/A | |
| Graft Type (%) | 1.00 | |||
| Peripheral blood | 42 (98) | 32 (100) | 24 (100) | |
| Bone Marrow | 1 (2) | 0 (0) | 0 (0) | |
| Type of Conditioning (%) | 0.36 | |||
| Myeloablative | 34 (79) | 21 (66) | 16 (67) | |
| Reduced Intensity Conditioning | 9 (21) | 11 (34) | 8 (23) | |
| Conditioning Regimen (%) | <0.001 | |||
| Clo/Bu | 15 (35) | 6 (19) | 0 (0) | |
| Bu/Cy | 14 (33) | 8 (25) | 0 (0) | |
| Flu/Bu ± Other | 12 (28) | 12 (38) | 3 (13) | |
| Cy/TBI ± Other | 1 (2) | 5 (16) | 0 (0) | |
| Flu/TBI | 1 (2) | 0 (0) | 13 (54) | |
| Flu/Melph | 0 (0) | 1 (3) | 2 (8) | |
| Flu/Cy/TBI | 0 (0) | 0 (0) | 6 (25) | |
| GvHD Prophylaxis (%) | <0.001 | |||
| (Tacro or Siro) + MTX | 31 (72) | 26 (81) | 0 (0) | |
| (Tacro or Siro) + MTX ± Other | 6 (13) | 0 (0) | 0 (0) | |
| (Tacro or Siro) + MMF ± Other | 5 (11) | 4 (13) | 24 (100) | |
| Other | 1 (2) | 2 (6) | 0 (0) |
*
Well-matched: no identifiable HLA mismatch at HLA-A, -B, -C, -DRB1, or -DQB1 locus; Partially-matched: one identifiable HLA mismatch at HLA-A, -B, -C, -DRB1, or -DQB1 locus; Mismatched: greater than one identifiable HLA mismatch at HLA-A, -B, -C, -DRB1, or -DQB1 locus